Financhill
Buy
58

H Quote, Financials, Valuation and Earnings

Last price:
$165.51
Seasonality move :
3.06%
Day range:
$163.99 - $165.99
52-week range:
$102.43 - $168.10
Dividend yield:
0.36%
P/E ratio:
36.79x
P/S ratio:
2.29x
P/B ratio:
4.51x
Volume:
188.9K
Avg. volume:
804.2K
1-year change:
4.34%
Market cap:
$15.7B
Revenue:
$6.7B
EPS (TTM):
-$0.92

H Analysts' Consensus Rating

The 19 analysts providing 12-month price projections for Hyatt Hotels Corp. shares anticipate an average target of $169.43, ranging from a low estimate of $145.00 to a high estimate of $203.00. This average target implies a growth of 2.39% compared to the current stock price of $165.48.

Consensus Price Target

$169.43

Highest Price Target

$203.00

Lowest Price Target

$145.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 7 10 10

Hold 13 9 9

Sell 0 0 0
Consensus Hold Buy Buy

H Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock